4.6 Article

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

Journal

JMIR MHEALTH AND UHEALTH
Volume 9, Issue 2, Pages -

Publisher

JMIR PUBLICATIONS, INC
DOI: 10.2196/23548

Keywords

WeChat management; chronic obstructive pulmonary disease; Baduanjin rehabilitation

Funding

  1. National Key Research and Development Program of China [2018YFC1313600]
  2. Shanghai Science and Technology Committee [18140904000, 17401970900]
  3. Department of Respiratory Medicine Development Fund of Putuo District [2016PTZK03]
  4. Scientific Innovation Foundation of Putuo District [ptkwws201714]
  5. Shanghai Municipal Commission of Health and Family Planning [20174Y0239]
  6. Peiying Program of Putuo Hospital [2017206A]
  7. scientific project of Shanghai University of Traditional Chinese Medicine [2019LK096]
  8. Specialty Construction of Respiratory and Critical Care Medicine [2020tszk02]

Ask authors/readers for more resources

The study shows that WeChat platform is an effective tool in managing Baduanjin exercise for COPD patients, leading to better patient compliance and enthusiasm, and positive outcomes in lung function and quality of life.
Background: Pulmonary rehabilitation is a crucial part of the nonpharmacological treatment of stable chronic obstructive pulmonary disease (COPD), but management remains problematic. WeChat could serve as a useful tool in patient management. Baduanjin is a popular exercise in China that is usually applied in pulmonary rehabilitation, which has been confirmed to be effective in improving lung function and life quality. Objective: This study aimed to explore the efficiency of WeChat in the management of Baduanjin exercise in COPD patients. Methods: A total of 200 patients from the respiratory department of Putuo Hospital participated in the Baduanjin rehabilitation project from September 2018 to October 2019, and were randomly assigned to the WeChat and control groups and followed up using the WeChat platform or telephone for 12 weeks. The frequency of Baduanjin exercise, lung function (percentage of forced expiratory volume in 1 second predicted, FEV1% predicted), and COPD assessment test (CAT) scores were collected and compared between the two groups. The number of message exchanges and a satisfaction survey on the WeChat platform were used to assess the feasibility of WeChat management outside the hospital. Results: The Baduanjin exercise frequency significantly differed between the control group and WeChat group (F=33.82, P<.001) and across various time points (F=214.87, P<.001). After the follow-up on WeChat, there were fewer patients not performing Baduanjin exercise. The FEV1% predicted value significantly differed before and after Baduanjin exercise in the control group (Z=& minus;3.686, P<.001) and the WeChat group (Z=& minus;6.985, P<.001). A significant difference in the FEV1% predicted value was observed after Baduanjin exercise between the two groups (Z=& minus;3.679, P<.001). The CAT score significantly differed before and after Baduanjin exercise in the control group (Z=& minus;4.937, P<.001) and the WeChat group (Z=& minus;5.246, P<.001). A significant difference in the CAT score was observed after Baduanjin exercise between the two groups (Z=& minus;5.246, P<.001). The number of completed Baduanjin exercises, lung function, and CAT scores in active patients were higher than those in nonactive patients. All satisfaction survey items were scored with more than 4 points. Among the items, the highest score (mean 4.54, SD 0.77) was for continued WeChat management, followed by the effective management of Baduanjin exercise (mean 4.46, SD 0.87). The patients in the WeChat group showed much higher enthusiasm for and compliance with Baduanjin exercise, resulting in better life quality and lung function. The patients were very satisfied with the WeChat management because of the obvious curative effect and home feeling. Conclusions: The WeChat platform provided a feasible, effective, and sustainable management plan for Baduanjin rehabilitation. Trial Registration: Chinese Clinical Trial Registry ChiCTR1900028248; http://www.chictr.org.cn/showprojen.aspx?proj=46995

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available